COMPARE CPM-RMI Trial: Intramyocardial Transplantation of\nAutologous Bone Marrow-Derived CD133+ Cells and MNCs\nduring CABG in Patients with Recent MI: A Phase II/III,\nMulticenter, Placebo-Controlled, Randomized,\nDouble-Blind Clinical Trial
Year: 2018
Type: article
Abstract: This article published in Cell J (Yakhteh), Vol 20, No 2, Jul-Sep 2018, on pages 267-277, four affiliations (1, 4, 5, and 10) were changed based on authors request.
Source: Europe PMC (PubMed Central)
Authors: Mohammad Hassan Naseri, Hoda Madani, Seyed Hossein Ahmadi Tafti, Maryam Moshkani Farahani, Davood Kazemi Saleh, Hossein Hosseinnejad, Saeid Hosseini, Sepideh Hekmat, Zargham Hossein Ahmadi, Majid Dehghani, Alireza Saadat, Soura Mardpour, Seyedeh Esmat Hosseini, Maryam Esmaeilzadeh, Hakimeh Sadeghian, Gholamreza Bahoush, Ali Bassi, Ahmad Amin, Roghayeh Fazeli, Yaser Sharafi, Leila Arab, Mansour Movahhed, Saeid Davaran, Narges Ramezanzadeh, Azam Kouhkan, Ali Hezavehei, Mehrnaz Namiri, Fahimeh Kashfi, Ali Akhlaghi, Fattah Sotoodehnejadnematalahi, Ahmad Vosough Dizaji, Hamid Gourabi, Naeema Syedi, Abdolhosein Shahverdi, Hossein Baharvand, Nasser Aghdami
Institutions: Baqiyatallah University of Medical Sciences, Royan Institute, Tehran Heart Center, Tehran University of Medical Sciences, Iran University of Medical Sciences, Shaheed Rajaei Cardiovascular Medical and Research Center, Masih Daneshvari Hospital, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences, Firoozgar General Hospital, Academic Center for Education, Culture and Research, University of South Australia
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4406431007